Evidence map›Paper›PMID 35448530›Full record

ReviewMetabolites2022

Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid.

Keiji Wakamatsu, Yoichi Chiba, Ryuta Murakami, Yumi Miyai, Koichi Matsumoto, Masaki Kamada, Wakako Nonaka, Naoya Uemura, Ken Yanase, Masaki Ueno

Open access · goldAbstract readReview
In one paragraph

Review in Metabolites, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Morphometry of choroid plexus epithelial cells in neurodegenerative diseases.Neuropathology : official journal of the Japanese Society of Neuropathology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Keiji WakamatsuDepartment of Pathology and Host Defense, Faculty of Medicine, Kagawa University, Miki-cho 761-0793, Japan.
Yoichi ChibaDepartment of Pathology and Host Defense, Faculty of Medicine, Kagawa University, Miki-cho 761-0793, Japan.
Ryuta MurakamiDepartment of Pathology and Host Defense, Faculty of Medicine, Kagawa University, Miki-cho 761-0793, Japan.
Yumi MiyaiDepartment of Pathology and Host Defense, Faculty of Medicine, Kagawa University, Miki-cho 761-0793, Japan.
Koichi MatsumotoDepartment of Pathology and Host Defense, Faculty of Medicine, Kagawa University, Miki-cho 761-0793, Japan.
Masaki KamadaDepartment of Neurological Intractable Disease Research, Faculty of Medicine, Kagawa University, Miki-cho 761-0793, Japan.
Wakako NonakaDepartment of Neurology, Faculty of Medicine, Kagawa University, Miki-cho 761-0793, Japan.
Naoya UemuraDepartment of Anesthesiology, Faculty of Medicine, Kagawa University, Miki-cho 761-0793, Japan.
Ken YanaseDepartment of Anesthesiology, Faculty of Medicine, Kagawa University, Miki-cho 761-0793, Japan.
Masaki UenoDepartment of Pathology and Host Defense, Faculty of Medicine, Kagawa University, Miki-cho 761-0793, Japan.
Kagawa University · JP

Funding

Japan Society for the Promotion of Science 17K08788, 19K07508, 20K16193, 20K16550
6 · The paper itself

Abstract

Despite recent advances in diagnostic procedures for neurological disorders, it is still difficult to definitively diagnose some neurodegenerative diseases without neuropathological examination of autopsied brain tissue. As pathological processes in the brain are frequently reflected in the components of cerebrospinal fluid (CSF), CSF samples are sometimes useful for diagnosis. After CSF is secreted from the choroid plexus epithelial cells in the ventricles, some flows in the brain, some is mixed with intracerebral interstitial fluid, and some is excreted through two major drainage pathways, i.e., the intravascular periarterial drainage pathway and the glymphatic system. Accordingly, substances produced by metabolic and pathological processes in the brain may be detectable in CSF. Many papers have reported changes in the concentration of substances in the CSF of patients with metabolic and neurological disorders, some of which can be useful biomarkers of the disorders. In this paper, we show the significance of glucose- and neurotransmitter-related CSF metabolites, considering their transporters in the choroid plexus; summarize the reported candidates of CSF biomarkers for neurodegenerative diseases, including amyloid-β, tau, α-synuclein, microRNAs, and mitochondrial DNA; and evaluate their potential as efficient diagnostic tools.

Indexed as

biomarkercerebrospinal fluidchoroid plexusepithelial cellmicroRNAtight junction

Identifiers

PMID35448530
PMCPMC9031591
OpenAlexW4223499227

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.